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Objective: The aim of this article is to characterize pathomorphologic changes within particular 
layers of fluorescein angiographically ‘ischemic’ compared to ‘nonischemic’ retina in patients 
with diabetic retinopathy.
Methods: Cross-sectional images of ischemic retinal areas were obtained using Heidelberg 
Spectralis optical coherence tomography (OCT). Presumed retinal ischemia was defined as focal 
hypofluorescence in early or early and late phase fluorescein angiography. Pathomorphologic 
changes on OCT were evaluated and the thickness of retinal layers measured and compared 
with nonischemic retina at corresponding topographic locations in a matched-pairs design based 
on 22 eyes (mean age 64 ± 14).
Results: In all eyes, based on spectral domain-OCT cross-section images, the retina layers in 
ischemic retinal areas could be segmented. Total retinal thickness was significantly increased 
in ischemic compared to nonischemic areas (381 ± 94 µm versus 323 ± 89 µm, P = 0.005). 
Middle retinal layers (inner nuclear layer, outer plexiform layer, and outer nuclear layer) were 
significantly thickened in retinal ischemic areas (215 ± 82 µm versus 168 ± 62 µm, P = 0.002). 
The inner retinal layers (retinal nerve fiber layer, ganglion cell layer, and inner plexiform layer) 
showed a nonsignificant change (117 ± 53 µm versus 98 ± 30 µm), while the outer layers 
were slightly thinned (photoreceptors plus retinal pigment epithelium layer; 51 ± 9 µm versus 
57 ± 8 µm, P = 0.02) in ischemic versus nonischemic retina.
Conclusions: Ischemic diabetic retina seems to be thickened due to thickening of, in particular, 
middle retinal layers, which can be measured with high-resolution OCT.
Keywords: OCT, Spectralis OCT, fluorescein angiography, diabetic retinopathy, ischemic retina, 
retinal thickness, retinal layers
Introduction
Diabetic retinopathy (DR) as an ocular manifestation of diabetes mellitus with its rap-
idly increasing prevalence is one of the leading causes for blindness in industrialized 
  countries.1 Usually, DR starts as a mild nonproliferative form, continues to develop 
first into a severe nonproliferative, and finally into a proliferative form of the disease. 
Accumulation of toxic sorbitol and metabolized end products of the glycosylation pro-
cess leads to microangiopathic changes of the retinal vessels which then in turn cause 
exudation, edema, hypoxia, and formation of new vessels on retinal level. The basic 
treatment of DR is to control blood sugar levels and blood pressure followed by focal 
or panretinal laser photocoagulation or pharmacologic treatments such as intravitreal 
anti-vascular endothelial growth factor as specific ophthalmological therapies to slow 
down the process of progression of the disease.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
32
Reznicek et al
Rapidly evolving and improving imaging techniques have 
made it possible to characterize the phenotype and pathologic 
changes of the retina. Using a   noninvasive optical coherence 
tomography (OCT) technique, it is possible to detect retinal 
changes such as macular edema or ischemia and depict them 
as progression parameters.2–4 Prior studies using OCT showed 
the possibility to image pathologic changes of particular 
retinal layers of patients or animal models with degenerative 
macular disease5 and ischemic retinopathy.6,7
The aim of this study was to identify ischemic retinal areas 
of patients with DR using fluorescein angiography (FA) and 
characterize pathophysiologic changes in particular retinal lay-
ers within these areas compared to nonischemic retina using 
the noninvasive spectral domain-OCT (SD-OCT) technique.
Methods
Patients
A total of 22 eyes from 16 consecutive patients undergo-
ing FA and SD-OCT (HRA-OCT, Heidelberg Engineering, 
Heidelberg, Germany) at the same day for the evaluation 
of DR at the Department of Ophthalmology, Ludwig 
Maximilian University, Munich, were included in this 
study. In total, 12 Caucasian men and 4 women with a mean 
age of 64 ± 14 (range 27–82 years) were included. All had 
known diabetes mellitus for at least 3 years, with the major-
ity of patients (n = 14) having diagnosed type 2 diabetes. 
All patients had nonproliferative DR. Objective refraction 
was mean +0.69 ± 1.91 sphere (minimum −4.25, maximum 
+4.0 D) and −1.06 ± 0.51 cylinder, while all cylinder was 
 2 D. Inclusion criteria were diagnosed diabetes and a 
mild or severe nonproliferative or proliferative DR with an 
ischemic area seen in FA located within major temporal blood 
vessels and at a distance of at least 500 µm from the fovea. 
Exclusion criteria were previous laser treatment in scanned 
and analyzed ischemic area, degenerative disorders of the 
posterior pole, or significant media opacities. In all patients, 
a full ophthalmological examination was performed, and both 
FA and SD-OCT were carried out after informed consent. 
All research was conducted in accordance with institutional 
guidelines and board approval and conformed to the tenets of 
the World Medical Association Declaration of Helsinki.
Procedures
A commercially available HRA-OCT (Heidelberg Engi-
neering) model was used for FA and SD-OCT examination. 
Wavelengths of HRA for FA and SD-OCT are 488 and 
870 nm, respectively. Optical resolution is ∼3.8 µm axial and 
6 µm lateral (high resolution mode). Acquisition speed for 
SD-OCT is 40,000 A-scans/sec. The scan depth is 1.9 mm.
FA was obtained for each study eye to determine the 
extent of the ischemic area being localized within major 
temporal retinal blood vessels. An ischemic area was defined 
as circumscribed hypofluorescence in early or early and late 
phase FA. A nonischemic area in corresponding topographic 
location (ie, mirrored around a horizontal axis through the 
optic nerve) was chosen as reference in each study eye. 
If more than one ischemic area was imaged, the selected area 
was chosen such that it was corresponding to the nonischemic 
area and the most distant to the macular center. By applying 
this selection rule, we could identify corresponding ischemic 
and nonischemic areas in all cases. An SD-OCT volume 
scan (using automatic real-time eye-tracking: average frame 
number, 9) of the macula covering the ischemic and corre-
sponding nonischemic areas within one scan was performed 
for each eye to visualize specific retinal layers and measure 
their thickness in micrometers (Figure 1A, B).
Measurements
Thickness of the whole retina and its singular layers dis-
played at SD-OCT cross-section images were measured by 
one person using ImageJ software (NIH, Bethesda, MD; see 
http://rsb.info.nih.gov/ij/disclaimer.html) to warrant repeat-
ability and to allow for measurements of nonperpendicular 
pictured retina. Measurements of ischemic retina were taken 
from the center of the affected area and analogous from the 
control area.
Retinal layers were segmented into three layers 
(Figure 2):
1.  Inner retinal layers: including retinal nerve fiber layer 
(RNFL), ganglion cell layer (GCL), and inner plexiform 
layer (IPL)
2.  Middle retinal layers including: inner nuclear layer (INL), 
outer plexiform layer (OPL)
3.  Outer retinal layers including: outer nuclear layer (ONL), 
the retinal pigment epithelium layer (RPE) and the inner 
choriocapillaris.
statistical analysis
Data were collected and analyzed using SPSS software 
(  version 17.0; SPSS Inc., Chicago, IL). A P value of ,0.05 
was considered as statistically significant. Univariate analy-
ses were applied, and paired testing (n = 22) and nonpara-
metrical methods were chosen, for example, Wilcoxon testing 
for paired differences.
Results
The obtained SD-OCT cross-section images of the retina 
allowed segmentation into the anatomical retinal layers in Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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all 22 cases in both fluorescein angiographic ischemic and 
the control area. Overall, mean retinal thickness in ischemic 
retina was 381 ± 94 µm compared to a mean retinal thick-
ness of 323 ± 89 µm of corresponding nonischemic retina 
(P = 0.005; Wilcoxon). This means that ischemic retina – 
nonischemic retina showed a mean retinal thickening of 
59 ± 82 µm with a 95% confidence interval from 22 to 95 µm. 
Figure 3 illustrates those findings.
Middle retinal layers (INL, OPL, and ONL) in ischemic 
retinal areas revealed a thickness of 215 ± 82 µm compared 
to 168 ± 62 µm in nonischemic retina (P = 0.002; Wilcoxon). 
This means a mean retinal thickening of 47 ± 67 µm with 
a 95% confidence interval from 17 to 76 µm (see Figure 4). 
Looking at the inner layers (RNFL, GCL, and IPL) of isch-
emic retina, the SD-OCT measurements revealed a thickness 
of 117 ± 53 µm compared to 98 ± 30 µm of nonischemic 
retina (P = 0.39). The outer retinal layers (photoreceptors 
and RPE) in ischemic retinal areas showed a slightly reduced 
thickness of 51 ± 9 µm compared to 57 ± 8 µm in   nonischemic 
retina (P = 0.02).
0
0.0 0 .5 1.0 1 .5 2.0
196
284
T
h
i
c
k
n
e
s
s
 
[
µ
m
]
Position [mm]
2.5 3 .0 3.5 4 .0
200
400
600
800
1000
0
0.0 0 .5 1.0 1 .5 2.0
T
h
i
c
k
n
e
s
s
 
[
µ
m
]
Position [mm]
2.5 3 .0 3.5 4 .0
200
400
600
800
1000
Figure 1 A) heidelberg spectralis optical coherence tomography image showing the retinal thickness (located superior temporally within major blood vessels) along the 
scan in micrometers with the marker located in ischemic retina of a left eye. B) Retinal thickness of the same eye in micrometers along the scan with the marker located in 
nonischemic retina at corresponding topographic location (which was selected to be ‘mirrored’ around a horizontal axis through the optic nerve).
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Figure  2  sD-OCT  scan  through  nonischemic  extrafoveal  retina  with  different 
hyper-reflective bands representing the anatomical retinal layers of the retina.
Abbreviations: RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; IPL, inner 
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer 
nuclear layer; IS/OS, interface of the inner and outer segments of the photoreceptor 
layer; RPE, retinal pigment epithelium layer; CHOR, inner choriocapillaris; SD-OCT, 
spectral domain optical coherence tomography.
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Figure 3 Mean retinal thickness in micrometers with standard deviation at ischemic 
(total_i) and nonischemic (total_ni) retina. Ischemic retina is significantly (P = 0.005) 
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To account for the different distances of the measured 
ischemic areas toward the macula center, in addition, we cal-
culated individual relative thickness: ischemic/nonischemic 
retinal thickness (Figure 5). A value of ‘1’ thus corresponds to 
equal retinal thickening, while values .1 indicate thickening 
and ,1 thinning of the fluorescein angiographic ischemic 
area. This analysis confirms the overall thickening and in 
particularly thickening of the middle retinal layers, as shown 
with absolute numbers in Figures 3 and 4.
Discussion
High-resolution OCT imaging allows for measurement of the 
thickness of segmented retinal layers in ischemic retinal areas. 
Hypofluorescent areas with mainly hyperfluorescent surround-
ings seen in FA in patients with DR were defined as ischemic 
areas. In this study, we were able to demonstrate a thickening 
of ischemic retina caused by thickening of, in particular, middle 
retinal layers in patients with DR. By measuring ischemic areas 
and comparing with nonischemic areas at corresponding loca-
tion of the same subject, we tried to exclude variables such as 
gender, ethnicity, age, and refraction that usually affect retinal 
thickness and thus could bias the results of measurements 
comparing different individuals.8–11
Besides glaucoma diagnosis, pathologic thickness altera-
tions regarding inner retinal layers can be seen in rare heredi-
tary retinopathies.12,13 Vascular pathologies of the retina can 
also modify the thickness of inner retinal layers such as central 
or branch retinal artery occlusion with an initial thickening and 
a final thinning of the inner retinal layers or ischemic macu-
lopathy in diabetic patients with a detectable atrophy of the 
foveal GCL.6,14,15 Other studies indicate an additional neurode-
generative component in DR by observing a reduced thickness 
of inner retinal layers in preclinical DR.16 Similar results were 
found in ischemic maculopathy in a recent study.15
Our measurements indicate a slight nonsignificant 
thickening rather than thinning of the inner retinal layers 
in angiographically apparent ischemic DR. Of note, our 
segmentation included IPL, which was measured together 
with GCL and RNFL and could account for the different 
results. Another possible explanation for our results could 
be an edematous swelling of the nonfoveal GCL prior to 
atrophic damage caused by ischemia. In our study, we 
also measured a slightly reduced thickness of the outer 
retinal layers in ischemic areas, which are in line with 
previously published reports on patients with no clinical 
evidence of DR, where the photoreceptor layer was found 
to be significantly reduced, which could be interpreted as 
an early damage to the neurosensory retina due to diabetic 
microangiopathy.17
Most clearly, in our study, we observed thickening of the 
middle retinal layers (INL, OPL, and ONL). Of note, retinal 
pathologies such as diffuse macular edema, cystoid macular 
edema, or exudates are found to occur in the middle retinal 
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Figure 4 Mean thickness, in micrometers, of ischemic (inner_i) and nonischemic 
(inner_ni)  inner  retinal  layers,  ischemic  (middle_i)  and  nonischemic  (middle_ni) 
middle  retinal  layers,  and  ischemic  (outer_i)  and  nonischemic  (outer_ni)  outer 
retinal layers. Data exceeding the 25 and 75 percentiles are shown as single rings. 
Of note, ischemic middle retinal layers are significantly thickened compared to 
nonischemic middle retinal layers.
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Figure 5 Relative thickness of ischemic/nonischemic retina for total retina (Ratio_
total) and the inner (Ratio_inner), middle (Ratio_outer), and outer (Ratio_outer) 
retinal layers. Data exceeding the 25 and 75 percentiles are shown as single rings.Clinical Ophthalmology
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layers and are responsible for retinal   thickening and hence need 
to be treated, for example, with laser photocoagulation.18,19 
However, by defining hypofluorescent areas seen in FA as 
ischemic retina, we did not differentiate between ischemic 
retina and hypofluorescence due to edema. The observed 
thickening may, therefore, be caused by accumulation of 
extracellular fluid from a leaking venous system approximat-
ing the underperfused areas which was observed in FA as 
hyperfluorescent surroundings (see   Figure 1A, B) and may be 
masking other intracellular changes such as retinal ischemia 
or even atrophy.
Another possibility to explain our observations on a more 
molecular basis is that fluid accumulates intracellularly in 
ischemic retinal areas and thus leads to cellular swelling with 
consecutive retinal thickening. In contrast, in type 1 diabetic 
patients with no or minimal retinal changes, retinal thinning 
was observed indicating chronic neurodegenerative damage 
before DR could evolve.20,21 Our findings of thickened isch-
emic retina due to primarily thickened middle retinal layers in 
patients with DR suggest an edematous process as a possible 
stage before advanced irreversible atrophic changes occur. 
Further studies are needed to investigate the importance of 
fluorescein angiographic ischemic areas for staging DR and 
to test for its reversibility.
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